Budúce P/E spoločnosti Acorda Therapeutics Inc
Aká je hodnota metriky Budúce P/E spoločnosti Acorda Therapeutics Inc?
Hodnota metriky Budúce P/E spoločnosti Acorda Therapeutics Inc je -18.33
Aká je definícia metriky Budúce P/E?
Budúci pomer P/E (Forward price to earnings ratio) vyjadruje pomer súčasnej ceny a odhadovaného zisku na akciu za ďalších 12 mesiacov.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Budúce P/E spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Acorda Therapeutics Inc
Čomu sa venuje spoločnosť Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Firmy s metrikou budúce p/e podobnou spoločnosti Acorda Therapeutics Inc
- Hodnota metriky Budúce P/E spoločnosti Reata Pharmaceuticals Inc je -18.42
- Hodnota metriky Budúce P/E spoločnosti Savara Inc je -18.41
- Hodnota metriky Budúce P/E spoločnosti Wrap Technologies je -18.41
- Hodnota metriky Budúce P/E spoločnosti Wrap Technologies je -18.41
- Hodnota metriky Budúce P/E spoločnosti Wrap Technologies je -18.41
- Hodnota metriky Budúce P/E spoločnosti Wrap Technologies je -18.41
- Hodnota metriky Budúce P/E spoločnosti Acorda Therapeutics Inc je -18.33
- Hodnota metriky Budúce P/E spoločnosti Wrap Technologies je -18.32
- Hodnota metriky Budúce P/E spoločnosti Wrap Technologies je -18.32
- Hodnota metriky Budúce P/E spoločnosti Liberty Gold je -18.20
- Hodnota metriky Budúce P/E spoločnosti SL Green Realty je -18.07
- Hodnota metriky Budúce P/E spoločnosti First Mining Gold je -18.00
- Hodnota metriky Budúce P/E spoločnosti Western Copper & Gold je -18.00